This pre-clinical startup focuses on the discovery and development of broad-spectrum treatments for chronic and severe infectious diseases. By utilizing host-directed therapy strategies, Affirma Biotech interferes with host cell factors necessary for pathogen replication or persistence. Their expertise lies in immunomodulation, allowing them to create new anti-infective drugs. With a specialization in this field, the company aims to revolutionize the treatment of infectious diseases through innovative drug development.